Compile Data Set for Download or QSAR
maximum 50k data
Found 23 Enz. Inhib. hit(s) with all data for entry = 9205
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM448916(US10696689, Compound 1-1)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449022(US10696689, Compound 3-19)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449002(2-[4-(4-aminopiperidin-1-yl)-2-(dimethylamino)-5-(...)
Affinity DataEC50: >1nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449003(US10696689, Compound 2-1 | US11186590, Compound 2-...)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449004(4-(4-aminopiperidin-1-yl)-3-(6-fluoro-4-methoxy-1H...)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449005(4-(4-aminopiperidin-1-yl)-3-(6-fluoro-4-methoxy-1H...)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449006(US10696689, Compound 3-1)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449007(US10696689, Compound 3-2)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449008(US10696689, Compound 3-3)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449009(US10696689, Compound 3-6)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449010(US10696689, Compound 3-7)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449011(US10696689, Compound 3-8)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449012(US10696689, Compound 3-9)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449013(US10696689, Compound 3-10)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449014(US10696689, Compound 3-11)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449015(US10696689, Compound 3-12)
Affinity DataEC50: >1nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449016(US10696689, Compound 3-13)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449017(US10696689, Compound 3-14)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449018(US10696689, Compound 3-15)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449019(2-{4-[(4αS,8αS)-octahydro-1H-pyrido[3,4-...)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449020(US10696689, Compound 3-17)
Affinity DataEC50: <0.100nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM449021(US10696689, Compound 3-18)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Crinetics Pharmaceuticals

US Patent
LigandPNGBDBM448999(US10696689, Compound 1-2)
Affinity DataEC50:  0.550nMAssay Description:On the day of the assay, the media is aspirated and the cells are treated with 50 μL of 1.6 μM NKH477 (Sigma # N3290) plus various dilution...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent